Literature DB >> 16949103

Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer.

Le Zhang1, Chaitanya A Athale, Thomas S Deisboeck.   

Abstract

Experimental evidence suggests that epidermal growth factor receptor (EGFR)-mediated activation of the signaling protein phospholipase Cgamma plays a critical role in a cancer cell's phenotypic decision to either proliferate or to migrate at a given point in time. Here, we present a novel three-dimensional multiscale agent-based model to simulate this cellular decision process in the context of a virtual brain tumor. Each tumor cell is equipped with an EGFR gene-protein interaction network module that also connects to a simplified cell cycle description. The simulation results show that over time proliferative and migratory cell populations not only oscillate but also directly impact the spatio-temporal expansion patterns of the entire cancer system. The percentage change in the concentration of the sub-cellular interaction network's molecular components fluctuates, and, for the 'proliferation-to-migration' switch we find that the phenotype triggering molecular profile to some degree varies as the tumor system grows and the microenvironment changes. We discuss potential implications of these findings for experimental and clinical cancer research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949103     DOI: 10.1016/j.jtbi.2006.06.034

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  64 in total

1.  Apolipoprotein E genotype and the association between C-reactive protein and postoperative delirium: Importance of gene-protein interactions.

Authors:  Sarinnapha M Vasunilashorn; Long H Ngo; Sharon K Inouye; Tamara G Fong; Richard N Jones; Simon T Dillon; Towia A Libermann; Margaret O'Connor; Steven E Arnold; Zhongcong Xie; Edward R Marcantonio
Journal:  Alzheimers Dement       Date:  2020-01-04       Impact factor: 21.566

2.  Multiparameter computational modeling of tumor invasion.

Authors:  Elaine L Bearer; John S Lowengrub; Hermann B Frieboes; Yao-Li Chuang; Fang Jin; Steven M Wise; Mauro Ferrari; David B Agus; Vittorio Cristini
Journal:  Cancer Res       Date:  2009-04-14       Impact factor: 12.701

3.  The role of extracellular matrix in glioma invasion: a cellular Potts model approach.

Authors:  Brenda M Rubenstein; Laura J Kaufman
Journal:  Biophys J       Date:  2008-10-03       Impact factor: 4.033

Review 4.  At the biological modeling and simulation frontier.

Authors:  C Anthony Hunt; Glen E P Ropella; Tai Ning Lam; Jonathan Tang; Sean H J Kim; Jesse A Engelberg; Shahab Sheikh-Bahaei
Journal:  Pharm Res       Date:  2009-09-09       Impact factor: 4.200

5.  Agent-Based Modeling of Systemic Inflammation: A Pathway Toward Controlling Sepsis.

Authors:  Gary An; R Chase Cockrell
Journal:  Methods Mol Biol       Date:  2021

Review 6.  In silico cancer modeling: is it ready for prime time?

Authors:  Thomas S Deisboeck; Le Zhang; Jeongah Yoon; Jose Costa
Journal:  Nat Clin Pract Oncol       Date:  2008-10-14

7.  Cancer cell motility: optimizing spatial search strategies.

Authors:  L Leon Chen; Le Zhang; Jeongah Yoon; Thomas S Deisboeck
Journal:  Biosystems       Date:  2008-11-14       Impact factor: 1.973

8.  Agent-based modeling of host-pathogen systems: The successes and challenges.

Authors:  Amy L Bauer; Catherine A A Beauchemin; Alan S Perelson
Journal:  Inf Sci (N Y)       Date:  2009-04-29       Impact factor: 6.795

9.  Identifying functional mechanisms of gene and protein regulatory networks in response to a broader range of environmental stresses.

Authors:  Cheng-Wei Li; Bor-Sen Chen
Journal:  Comp Funct Genomics       Date:  2010-04-28

10.  Dynamic computational model suggests that cellular citizenship is fundamental for selective tumor apoptosis.

Authors:  Megan Olsen; Nava Siegelmann-Danieli; Hava T Siegelmann
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.